Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 8
1989 2
1990 2
1991 2
1992 3
1993 1
1994 4
1995 2
1996 3
1997 2
1998 2
2000 2
2002 1
2003 4
2004 5
2006 3
2007 2
2008 3
2009 3
2010 1
2011 1
2012 3
2013 5
2014 2
2015 1
2016 2
2017 7
2018 8
2019 2
2020 2
2021 9
2022 10
2023 12
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and Management.
Lioncino M, Monda E, Verrillo F, Moscarella E, Calcagni G, Drago F, Marino B, Digilio MC, Putotto C, Calabrò P, Russo MG, Roberts AE, Gelb BD, Tartaglia M, Limongelli G. Lioncino M, et al. Heart Fail Clin. 2022 Jan;18(1):19-29. doi: 10.1016/j.hfc.2021.07.004. Epub 2021 Oct 25. Heart Fail Clin. 2022. PMID: 34776080 Free PMC article. Review.
Diagnosis of RASopathy can be triggered by clinical clues ("red flags") which may direct the clinician toward a specific gene test. Compared with sarcomeric hypertrophic cardiomyopathy, hypertrophic cardiomyopathy in RASopathies (R-HCM) is associated w …
Diagnosis of RASopathy can be triggered by clinical clues ("red flags") which may direct the clinician toward a specific gene test. Compared …
Cardiology: hypertrophic cardiomyopathy.
Medical Masterclass contributors; Firth J. Medical Masterclass contributors, et al. Clin Med (Lond). 2019 Jan;19(1):61-63. doi: 10.7861/clinmedicine.19-1-61. Clin Med (Lond). 2019. PMID: 30651247 Free PMC article. Review. No abstract available.
Targeting the sarcomere in inherited cardiomyopathies.
Lehman SJ, Crocini C, Leinwand LA. Lehman SJ, et al. Nat Rev Cardiol. 2022 Jun;19(6):353-363. doi: 10.1038/s41569-022-00682-0. Epub 2022 Mar 18. Nat Rev Cardiol. 2022. PMID: 35304599 Free PMC article. Review.
Variants in >12 genes encoding sarcomeric proteins can cause various cardiomyopathies. The two most common are hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Current therapeutics do not target the root causes of these diseases, but att …
Variants in >12 genes encoding sarcomeric proteins can cause various cardiomyopathies. The two most common are hypertrophic car …
Minor hypertrophic cardiomyopathy genes, major insights into the genetics of cardiomyopathies.
Walsh R, Offerhaus JA, Tadros R, Bezzina CR. Walsh R, et al. Nat Rev Cardiol. 2022 Mar;19(3):151-167. doi: 10.1038/s41569-021-00608-2. Epub 2021 Sep 15. Nat Rev Cardiol. 2022. PMID: 34526680 Review.
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian disease but is now increasingly recognized as having a complex genetic aetiology. ...Genes associated with Mendelian cardiomyopathy are enriched in the putative c …
Hypertrophic cardiomyopathy (HCM) was traditionally described as an autosomal dominant Mendelian disease but is now increasing …
Causes of sudden cardiac death in young athletes and non-athletes: systematic review and meta-analysis: Sudden cardiac death in the young.
D'Ascenzi F, Valentini F, Pistoresi S, Frascaro F, Piu P, Cavigli L, Valente S, Focardi M, Cameli M, Bonifazi M, Metra M, Mondillo S. D'Ascenzi F, et al. Trends Cardiovasc Med. 2022 Jul;32(5):299-308. doi: 10.1016/j.tcm.2021.06.001. Epub 2021 Jun 22. Trends Cardiovasc Med. 2022. PMID: 34166791 Review.
Comparing the causes of SCD between athletes and non-athletes, non-ischemic left ventricular scar (NILVS) (5.1% vs. 1.1%, p=0.01) was more frequent in the former, while coronary artery disease (CAD) (19.6% vs. 9.1%, p=0.009), arrhythmogenic cardiomyopathy (ACM) (11. …
Comparing the causes of SCD between athletes and non-athletes, non-ischemic left ventricular scar (NILVS) (5.1% vs. 1.1%, p=0.01) was more f …
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management.
Litt MJ, Ali A, Reza N. Litt MJ, et al. Vasc Health Risk Manag. 2023 Apr 6;19:211-221. doi: 10.2147/VHRM.S365001. eCollection 2023. Vasc Health Risk Manag. 2023. PMID: 37050929 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is widely recognized as one of the most common inheritable cardiac disorders. ...
Hypertrophic cardiomyopathy (HCM) is widely recognized as one of the most common inheritable cardiac disorders. ...
Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain.
Tanaka H. Tanaka H. J Echocardiogr. 2021 Jun;19(2):71-79. doi: 10.1007/s12574-020-00508-3. Epub 2021 Jan 18. J Echocardiogr. 2021. PMID: 33460030 Free PMC article. Review.
It is commonly detected in athletes, arterial hypertension, aortic stenosis, hypertrophic cardiomyopathy, cardiac amyloidosis, Fabry disease, or Friedreich's ataxia. ...
It is commonly detected in athletes, arterial hypertension, aortic stenosis, hypertrophic cardiomyopathy, cardiac amyloidosis, …
Obstructive hypertrophic cardiomyopathy: a review of new therapies.
Mehra N, Ali AH, Desai MY. Mehra N, et al. Future Cardiol. 2023 Oct;19(13):661-670. doi: 10.2217/fca-2023-0056. Epub 2023 Nov 7. Future Cardiol. 2023. PMID: 37933625 Review.
Hypertrophic cardiomyopathy (HCM) is a phenotypically heterogeneous disease with a genetic basis and variable penetrance. ...Herein, we describe a new class of drugs targeting the specific pathophysiology of HCM. Hypertrophic obstructive cardiomyopathy …
Hypertrophic cardiomyopathy (HCM) is a phenotypically heterogeneous disease with a genetic basis and variable penetrance. ...H …
Imaging in Hypertrophic Cardiomyopathy: Beyond Risk Stratification.
Nealy Z, Kramer C. Nealy Z, et al. Heart Fail Clin. 2023 Oct;19(4):419-428. doi: 10.1016/j.hfc.2023.03.004. Epub 2023 Apr 29. Heart Fail Clin. 2023. PMID: 37714584 Review.
A multimodality imaging evaluation in hypertrophic cardiomyopathy is often used for risk stratification. Recent developments in imaging have allowed for better diagnosis, prognosis, and decision-making for a variety of therapies from medical to interventional. ...
A multimodality imaging evaluation in hypertrophic cardiomyopathy is often used for risk stratification. Recent developments i …
111 results